This Nystatin 20000 Units/g Sucralfate 200 mg/g Topical Gel is a semisolid formulation designed for easy and precise application on the skin through a convenient pump mechanism. The gel-like consistency ensures targeted treatment and effective absorption of active ingredients.
This formulation is used to treat skin conditions such as fungal infections and ulcers, providing relief and promoting healing by combining the antifungal properties of Nystatin with the protective and soothing effects of Sucralfate.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
The semisolid gel is dispensed through a pump mechanism, allowing for easy and precise application to the affected areas on the skin.
Nystatin is an antifungal agent that works by binding to sterols in the fungal cell membrane, altering its permeability and leading to the leakage of essential cellular components.
Sucralfate acts as a topical protectant by forming a viscous, adhesive substance that adheres to epithelial cells and ulcerated tissue. This creates a protective barrier over wounds and inflamed areas, promoting healing and providing a conducive environment for tissue regeneration.
The combination of Nystatin and Sucralfate in this gel formulation offers both antifungal activity and protective healing properties. Nystatin addresses the fungal infection by targeting and eliminating susceptible fungi, while Sucralfate safeguards the affected area, reducing irritation and facilitating the natural healing process of the skin or mucous membranes.
This compounded gel is intended for use in patients with fungal skin infections where additional mucosal protection is beneficial. It may be particularly useful in treating conditions such as intertrigo, diaper dermatitis, or other inflammatory skin conditions complicated by candidal infections that require both antifungal treatment and protective care.
Patients should apply a measured amount of the gel to the affected area as directed by their healthcare provider, typically applying a thin layer two to four times daily. The pump mechanism ensures accurate dosing and minimizes waste, enhancing ease of use. It is important to cleanse the area before application and wash hands thoroughly after applying the gel to prevent the spread of infection.
As with all medications, potential side effects may occur. Nystatin is generally well-tolerated but may cause local irritation, itching, or allergic reactions in some individuals. Sucralfate is also typically safe when used topically but may cause mild skin reactions. Patients should discontinue use and consult their healthcare provider if they experience severe irritation, rash, or signs of an allergic reaction.
Prescribers considering this formulation for their patients should assess the individual’s condition to determine the appropriateness of combining antifungal therapy with mucosal protection. The compounded gel allows for targeted delivery of medications to the site of infection and inflammation, potentially improving patient adherence and treatment outcomes through convenient application and dual therapeutic action.
If you have any questions, reach out to us.
Nystatin 20000 Units/g Sucralfate 200 mg/g Topical Gel is a compounded formulation designed for targeted treatment of skin conditions that may benefit from the antifungal properties of nystatin and the protective, soothing effects of sucralfate.
When considering the use of this topical gel, it is important to be aware of potential drug interactions, although they are generally less common with topical formulations compared to systemic medications. However, certain interactions may still occur, particularly if the patient is using other topical or systemic medications concurrently.
Patients using other topical medications should be cautious, as the concurrent application of multiple topical agents can lead to altered absorption or efficacy. For instance, applying other antifungal or corticosteroid creams simultaneously may either potentiate or diminish the effects of nystatin or sucralfate. It is advisable to apply different topical medications at different times of the day to minimize potential interactions.
Systemic medications are less likely to interact with this topical gel, but prescribers should still consider the patient's overall medication regimen. For example, patients on systemic antifungal therapy should be monitored for potential additive effects, although this is more of a theoretical concern with topical nystatin. Additionally, patients taking medications that affect skin integrity or healing, such as certain immunosuppressants or chemotherapy agents, should be monitored closely, as these could potentially alter the skin's response to the topical treatment.
Patients with known hypersensitivity to nystatin, sucralfate, or any component of the formulation should avoid using this gel. Furthermore, if the patient experiences any unexpected skin reactions, such as increased irritation, redness, or signs of an allergic reaction, they should discontinue use and consult their healthcare provider.
For prescribers, it is crucial to review the patient's full medication list, including over-the-counter products and supplements, to assess for any potential interactions. Additionally, educating patients on the proper application technique and advising them to report any adverse effects or concerns can help optimize treatment outcomes.
If you have any questions or need further information regarding the use of Nystatin 20000 Units/g Sucralfate 200 mg/g Topical Gel, please reach out to us. Our team of compounding pharmacists at Bayview Pharmacy is here to assist you with any inquiries or concerns you may have.
The Nystatin 20000 Units/g Sucralfate 200 mg/g Topical Gel is a specialized formulation designed to deliver targeted treatment through a semisolid gel dispensed via a pump mechanism. This innovative delivery system ensures easy and precise application, allowing for optimal absorption of the active ingredients directly at the site of need. The gel-like consistency enhances adherence to the skin, providing a protective barrier while facilitating the sustained release of the active compounds.
Nystatin is an antifungal agent that works by binding to sterols in the cell membrane of susceptible fungi, primarily Candida species. This binding disrupts the fungal cell membrane, causing leakage of cellular contents and ultimately leading to cell death. The localized application minimizes systemic absorption, reducing the risk of systemic side effects and drug interactions.
Sucralfate, on the other hand, is a cytoprotective agent that acts by forming a viscous, adhesive barrier on the skin's surface. This barrier protects the underlying tissue from further irritation and promotes healing by maintaining a moist environment conducive to tissue repair. Sucralfate's ability to bind to proteins in damaged tissue enhances its protective action, making it particularly useful in treating skin conditions characterized by ulceration or erosion. By combining Sucralfate with Nystatin in a topical gel, the formulation not only addresses fungal infections but also aids in the healing of the affected skin, providing a dual therapeutic action.
This formulation is particularly beneficial for patients with conditions such as intertrigo, diaper dermatitis, or other skin irritations complicated by fungal infections. The pump mechanism ensures that patients and caregivers can apply the gel with precision, reducing waste and ensuring consistent dosing.
If you have any questions or need further information about this formulation, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to assist you with any inquiries or concerns you may have regarding the use of this topical gel.
This topical gel is used for treating skin conditions that may benefit from the antifungal properties of Nystatin and the protective, soothing effects of Sucralfate. It is often used for targeted treatment of fungal infections and to promote healing of irritated skin.
The gel should be applied to the affected area of the skin using the pump mechanism for precise dosing. Ensure the skin is clean and dry before application. Follow your healthcare provider's instructions regarding the frequency and amount of gel to use.
It is generally not recommended to apply this gel on open wounds unless directed by a healthcare professional. Consult your doctor for advice specific to your condition.
Some users may experience mild skin irritation, redness, or itching at the application site. If you experience severe reactions or symptoms persist, discontinue use and consult your healthcare provider.
The pump mechanism is designed to dispense a consistent amount of gel with each use, ensuring easy and precise application. Simply press the pump to release the gel onto your skin or a clean applicator.
While the gel can be used on various parts of the body, it is important to avoid contact with the eyes and mucous membranes. Consult your healthcare provider before using it on sensitive areas like the face.
Store the gel at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets to prevent accidental ingestion or misuse.
If you are pregnant or breastfeeding, consult your healthcare provider before using this gel to ensure it is safe for you and your baby.
Before using this gel with other topical treatments, consult your healthcare provider to avoid potential interactions or reduced effectiveness of the medications.
If you miss a dose, apply the gel as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)